Prof. Dr. Meike Burger

• 1987 – 1993
  Studies in Medicine, University of Freiburg, Germany, and University of Vienna, Austria; foundation year in Freiburg and in Zurich, Switzerland
  
  

• 1991 – 1992
  Doctoral thesis, Institute of Surgical Research, University Hospital of Freiburg
  
  

• 1994 – 1995
  Internship: Department of Internal Medicine, Division of Nephrology, University Hospital of Freiburg
  
  

• 1995 – 1996
  10 month of parental leave
  
  

• 1996 – 1999
  Postdoc, Scripps Research Institute and Institute for Experimental Medicine, La Jolla, CA, USA
  
  

• 1998
  5 months of parental leave
  
  

• 2000 – 2001
  Internship: Department. of Internal Medicine, Division of Nephrology, University Hospital of Freiburg
  
  

• Since 2001
  junior research group leader, Emmy Noether fellow (until 6/2004), and speciality training in Laboratory Medicine, Department of Hematology/Oncology, University Hospital of Freiburg
  
  

• Since 2006
  Clinical training in Hemostaseology
  
  

• Since 2007
  Specialist in Laboratory Medicine, Head of diagnostic laboratories and tumur bank, Department of Haematology/Oncology
  
  

• 2009 – 2011
  Head of the Freiburg Cord Blood Bank
  
  

• Since 2010
  Senior consultant, Department of Haematology/Oncology
  
  

• 2011
  Additional specialisation in haemostaseology
  
  

• Since 2012
  Professor of Molecular Medicine in the Faculty of Medical and Life Sciences, Hochschule Furtwangen University, Germany
  
  

• Taromi S, Kayser G, Catusse J, von Elverfeldt D, Reichardt W, Braun F, Weber WA, Zeiser R, Burger M (2016). CXCR4 antagonists suppress Small Cell Lung Cancer progression. Oncotarget. 2016 Dec 20;7(51):85185-85195.

• Taromi S, Kayser G, von Elverfeldt D, Reichardt W, Braun F, Weber WA, Zeiser R, Burger M. (2016) An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients. Clin Exp Metastasis. 2016 Oct;33(7):651-60.

• Krohn A, Ahrens T, Yalcin A, Plönes T, Wehrle J, Taromi S, Wollner S, Follo M, Brabletz T, Mani S, Claus R, Hackanson B, Burger M (2014) Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes. PLosOne Jun 24;9(6):e100249

• Catusse J, et.al. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia. In: Mol Cancer. 2010 Nov 22;9:297.

• Catusse, J. et al.: Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B-cells. In: J Cell Physiol. 2010 Nov;225(3):792-800.

• Leick, M. et al.: CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. In: Immunology 129(4), 2010. S. 536-46.

• Hartmann, T.N. et al.: CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. In: Oncogene 24, 2005. S. 4462-4471.

• Burger, M. et al. (2005): Small Peptide Inhibitors of the CXCR4 Chemokine Receptor (CD184) Antagonize the Activation, Migration and Antiapoptotic Responses of CXCL12 in Chronic Lymphocytic Leukemia B Cells. In: Blood 106(5), 2005. S. 1824-30.

• Burger, M. et al.: KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a Jak2-STAT3 dependent pathway. In: Oncogene 24, 2005. S. 2067-2075.

• Burger, M. et al.: Functional expression of CXCR4 (CD184) on small cell lung cancer cells (SCLC) mediates migration, integrin activation, and adhesion to stromal cells. In: Oncogene 22, 2003. S. 8093-8101.

• Burger, M. et al.: Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. In: J. Immunol 163(4), 1999. s. 2017-22.

• project C3: The Chemokine receptor CXCR4 in Small Cell Lung Cancer (SCLC) and its role in metastasis (SFB 850: Control of cell motility in morphogenesis, cancer invasion and metastasis)

• project B5: Role of chemokine receptors in B cell maturation processes (Translational research platform of the Center for Chronic Immunodeficiency)

Memberships:

• German Society for Hematology and Oncology (DGHO)

• German Society for Immunology (DGfI)

• Society for Signal Transduction

• German Association of University Professors and Lecturers (Deutscher Hochschulverband, DHV)

expert assessments/reviews for:

• international peer reviewed journals

• scientific bodies, e.g. DFG

Other activities and achievements/family

• 3 children